Physician profile
Jeffrey Goldberg
NPI 1417158114
$56,737.64
in general payments reported to CMS, 2019-2025
22 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $13K · 2021: $4,526 · 2022: $10K · 2023: $2,896 · 2024: $921 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $1,653 · Honoraria: $1,500 · Gift: $16.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,118.00 |
| Food and Beverage | $1,652.80 |
| Honoraria | $1,500.00 |
| Gift | $16.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurotech Pharmaceuticals, INC. | $11,725.00 | 2025 | Encelto |
| Aerie Pharmaceuticals, INC. | $11,119.23 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $10,888.40 | 2019-2024 | Cirrus Hd-Oct, Plex Elite |
| Alcon Research LLC | $6,945.25 | 2022 | |
| Thea Pharma INC. | $4,250.00 | 2022-2023 | Iyuzeh |
| F. Hoffmann-La Roche Ag | $2,177.50 | 2021 | |
| Ptc Therapeutics, INC. | $2,000.00 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $1,500.00 | 2025 | |
| Alcon Vision LLC | $1,471.45 | 2019-2025 | Hydrus Microstent, Rocklatan, Centurion |
| Regeneron Pharmaceuticals, INC. | $1,381.45 | 2019-2022 | |
| Genentech, INC. | $1,120.00 | 2019 | |
| Biocryst Pharmaceuticals, INC. | $843.00 | 2025 | |
| Glaukos Corporation | $390.90 | 2024-2025 | Gonioprism Clip, Idose |
| Sight Sciences, INC. | $366.33 | 2019-2024 | Omni Surgical System |
| Nova Eye, INC. | $314.00 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $57.25 | 2023-2024 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Dompe US, INC. | $37.31 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $36.73 | 2022 | |
| Iridex Corporation | $33.60 | 2023 | |
| Nobel Biocare USA | $32.14 | 2021 | |
| Mallinckrodt Enterprises LLC | $28.70 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.